Lakhani, Sunil R.
Sunil R Lakhani
VIAF ID: 9078652 (Personal)
Permalink: http://viaf.org/viaf/9078652
Preferred Forms
-
- 100 1 _ ‡a Lakhani, Sunil R
-
-
-
-
- 100 1 _ ‡a Lakhani, Sunil R.
-
- 100 1 _ ‡a Lakhani, Sunil R.
-
- 100 1 _ ‡a Lakhani, Sunil R.
-
- 100 1 _ ‡a Lakhani, Sunil R.
- 100 0 _ ‡a Sunil R Lakhani
4xx's: Alternate Name Forms (6)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Basic pathology : an introduction to the mechanisms of disease | |
Biopsy pathology of the breast, c2001: | |
General pathology, microbiology, and immunology for health care students | |
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer | |
Malignant myoepithelioma | |
The mammary myoepithelial cell--Cinderella or ugly sister? | |
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? | |
Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers | |
Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. | |
Metaplastic breast carcinomas are basal-like tumours | |
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis | |
Microarray and histopathological analysis of tumours: the future and the past? | |
MicroRNA-182-5p targets a network of genes involved in DNA repair | |
miR-139-5p is a regulator of metastatic pathways in breast cancer | |
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology. | |
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes | |
Molar tooth development in caspase-3 deficient mice. | |
Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components | |
Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis. | |
Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast | |
Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes | |
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. | |
The molecular genetics of breast cancer: the contribution of comparative genomic hybridization | |
Molecular pathology in cancer research | |
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas | |
Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer | |
MR imaging of the skin and nipple of the breast: differentiation between tumour recurrence and post-treatment change | |
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research | |
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. | |
Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation | |
Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women | |
Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation | |
Natural sunscreen revealed | |
Next-Generation Sequencing of Endobronchial Ultrasound Transbronchial Needle Aspiration Specimens in Lung Cancer. | |
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study | |
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer | |
Papillary and neuroendocrine breast lesions: the WHO stance | |
Pathologic quiz case: a 62-year-old woman with a 4.5-cm nodule in the right breast. Lipid-rich breast carcinoma | |
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. | |
Phenotype-genotype correlation in familial breast cancer | |
Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications | |
Phyllodes tumours of the breast: a consensus review | |
Practical atlas of pseudomalignancy : benign lesions mimicking malignancy | |
Profiling copy number alterations in cell-free tumour DNA using a single-reference | |
Progesterone receptor-positive eruptive syringoma associated with diabetes. | |
Proliferation and differentiation in the human breast during pregnancy | |
Putting the brakes on cylindromatosis? | |
Rare variants in the ATM gene and risk of breast cancer | |
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. | |
Recent advances in breast cancer research impacting clinical diagnostic practice | |
Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features | |
Role of the executioner caspases during lens development. | |
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer | |
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer | |
Somatic mutations of the protein kinase gene family in human lung cancer | |
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo | |
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast | |
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary | |
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group | |
Subtypes of familial breast tumours revealed by expression and copy number profiling | |
Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia. | |
The teaching of pathology at St. George's Hospital Medical School, London | |
A test of performance of breast MRI interpretation in a multicentre screening study. | |
The topography of mutational processes in breast cancer genomes | |
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer | |
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor | |
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization | |
Typical medullary breast carcinomas have a basal/myoepithelial phenotype. | |
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS) | |
What's in a cancer syndrome? Genes, phenotype and pathology | |
WHO classification of tumours of the breast | |
The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours |